摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[2-(2-Methoxyethoxy)ethoxy]ethyl-diphenylphosphane | 351333-45-4

中文名称
——
中文别名
——
英文名称
2-[2-(2-Methoxyethoxy)ethoxy]ethyl-diphenylphosphane
英文别名
——
2-[2-(2-Methoxyethoxy)ethoxy]ethyl-diphenylphosphane化学式
CAS
351333-45-4
化学式
C19H25O3P
mdl
——
分子量
332.379
InChiKey
HFIBOFOVZCYXMS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    23
  • 可旋转键数:
    11
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.37
  • 拓扑面积:
    27.7
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    新型半不稳定两亲性膦的合成。钌(II)的络合性质和催化氢加成反应
    摘要:
    新的功能化膦R-(C 6 H 4)(OCH 2 CH 2)n PPh 2 { 1(R =叔辛基,n = 1),2(R =叔辛基,n = 5),3(R =叔辛基,ñ = 13),4(R = ñ壬基,ñ = 1.4),5(R = ñ壬基,ñ = 5),6(R = ñ壬基,ñ = 11)}, CH3(OCH 2 CH 2)3 PPh 2(7),CH 3(OCH 2 CH 2)3 PPhR(8,R =异戊基)和HOCH 2 CH 2(OCH 2 CH 2)2 PPhR(9,R = n-辛基)已合成。这些配体在同一分子中包含聚醚和疏水基团,因此可以导致结合了半不稳定(聚醚基团)和两亲(疏水和亲水基团)特性的化合物。进行了Ru(II)的络合研究,并表征了异常的三齿(O,O,P)配位模式。在CO和[RuCl 2(8)(PPh 3)]反应后,从三齿(O,O,P)配位模式向双齿(O,P)和单齿(P)演化显示了半不稳定性。。双核[Ru
    DOI:
    10.1021/om9905916
点击查看最新优质反应信息

文献信息

  • Process for the manufacture of saturated mono- or polycyclic compounds
    申请人:Cognis IP Management GmbH
    公开号:EP2179980A1
    公开(公告)日:2010-04-28
    Suggested is a process for the manufacture of saturated mono- or polycyclic compounds via hydrogenation of the respective unsaturated mono- or polycyclic compounds, which is characterised in that the reaction is conducted in an aqueous/organic two phase system in the presence of a water soluble catalyst consisting of a Group VIII metal and a hydrophilic ligand.
    建议采用一种工艺来制造饱和的单环或多环化合物,该工艺通过对相应的不饱和的单环或多环化合物进行氢化反应实现,其特征在于该反应在/有机两相体系中,在溶性催化剂的存在下进行,该催化剂由第八族属和亲配体组成。
  • Process for the partial hydrogenation of fatty acid esters
    申请人:Cognis IP Management GmbH
    公开号:EP1918358A1
    公开(公告)日:2008-05-07
    Suggested is a process for the manufacture of unsaturated fatty acid alkyl esters or glycerides having a total content of C18:1 of about 30 to about 80 Mol-% by partial hydrogenation of unsaturated fatty acid esters having a total content of (C18:2+C18:3) of at least 65 Mol-% - calculated on the total amount of C18 moieties in the ester - which is characterised in that the hydrogenation is conducted in an aqueous/organic two phase system in the presence of a water soluble catalyst consisting of a Group VIII metal and a hydrophilic ligand.
    本发明提出了一种通过部分氢化不饱和脂肪酸酯来制造不饱和脂肪酸烷基酯 或甘油酯的工艺,不饱和脂肪酸烷基酯或甘油酯的 C18:1 总含量约为 30 至 80 Mol-%,不饱和脂肪酸酯的 C18:2+C18:3)至少为 65 Mol-%(按酯中 C18 分子总量计算)的不饱和脂肪酸酯进行部分氢化,其特征在于氢化是在由第八族属和亲配位体组成的溶性催化剂存在下,在/有机两相体系中进行的。
  • Palladium(II) complexes with hemilabile amphiphilic phosphines
    作者:Esteve Valls、Joan Suades、René Mathieu、Joan F Piniella、Angel Alvarez-Larena
    DOI:10.1016/s0022-328x(01)00663-5
    日期:2001.4
    A series of trans-PdCl2L2 complexes were prepared and characterized with the following hemilabile amphiphilic phosphines: R-(C6H4)-(OCH2CH2)(n)-PPh2 1 (R = tert-octyl, n = 1), 2 (R = tert-octyl, (n) over bar = 5), 3 (R = tert-octyl, (n) over bar = 13), 4 (R = n-nonyl, (n) over bar = 1.4), 5 (R = n-nonyl, (n) over bar = 5), 6 (R = n-nonyl, (n) over bar = 11)}, CH3(OCH2CH2)(3)PPh2 (7), CH3(OCH2CH2)(3)PPhR (8, R = isopentyl) and HOCH2CH2(OCH2CH2)(2)PPhR (9, R=n-octyl). The molecular structure of trans-PdCl2(1)(2) was determined by X-ray crystallography. The reaction between the trans-PdCl2L2 complexes and Ag+. was studied by P-31-NMR spectroscopy. The formation of chelated P boolean ANDO species in tetrahydrofuran solution was observed in complexes with ligands 2, 3, 5, 6, 7, 8 and 9. However, with ligand 1 the formation of chelated species was only observed in the less coordinating solvent dichloromethane. This different behavior can be attributed to the electronic and steric effects of the aryl group bonded to the oxygen atom. Ligand 4 is a mixture of a molecule similar to 1 and molecules with more than one oxygen atom and thus displays both characteristics. (C) 2001 Elsevier Science B.V. All rights reserved.
  • US8263794B2
    申请人:——
    公开号:US8263794B2
    公开(公告)日:2012-09-11
  • [EN] PROCESS FOR THE PARTIAL HYDROGENATION OF FATTY ACID ESTERS<br/>[FR] PROCÉDÉ D'HYDROGÉNATION PARTIELLE D'ESTERS D'ACIDES GRAS
    申请人:COGNIS IP MAN GMBH
    公开号:WO2008043454A1
    公开(公告)日:2008-04-17
    [EN] Suggested is a process for the manufacture of unsaturated fatty acid alkyl esters or glycerides having a total content of C 18:1 of about 30 to about 80 Mol-% by partial hydrogenation of unsaturated fatty acid esters having a total content of (C18:2+C18:3) of at least 65 Mol-% - calculated on the total amount of C18 moieties in the ester - which is characterised in that the hydrogenation is conducted in an aqueous/organic two phase system in the presence of a water soluble catalyst consisting of a Group VIII metal and a hydrophilic ligand.
    [FR] La présente invention concerne un procédé de fabrication d'esters alkyliques d'acides gras insaturés ou glycérides ayant une teneur totale en C18:1 d'environ 30 à environ 80 % en moles par hydrogénation partielle d'esters d'acides gras insaturés ayant une teneur totale en (C18:2 + C18:3) d'au moins 65 % en moles - calculés par rapport à la teneur totale en groupements C18 dans l'ester. Ce procédé est caractérisé en ce que l'hydrogénation est effectuée dans un système biphasique aqueux/organique en présence d'un catalyseur soluble dans l'eau consistant en un métal du groupe VIII et un ligand hydrophile.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫